Wei Ning Health recently stated at the 2026 semi-annual report exchange meeting that the company's AI-related revenue is divided into two parts: first, the AI-native Winex platform has fully integrated basic capabilities such as AI models and agents, and is promoting intelligent transformation in all scenarios; second, incremental AI products from the AI Medical Division have released 8 products in the first half of 2026, and related contract orders have increased significantly compared to 2025. At the same time, the number of independent AI projects is gradually increasing. In the past, AI projects were mostly integrated into large projects, but now more and more customers set independent budgets for AI, and market returns are more guaranteed. Currently, there are two AI products most recognized by customers: MedMap and AI critical care systems.

Disclaimer:Webull uses external vendor Google Translation Service for news translations where we endeavour to ensure these are correct, however, we recommend that you please double-check this information accordingly. Webull is not responsible for translation errors or issues.